A non-classical type of alveolar macrophage response to Trichinella spiralis infection

Parasite Immunology

Volumn 26, Issue 4, 2004, Pages 197-205

  Dzik, J M ^a   Golos B ^a   Jagielska, E ^a   Zielinski, Z ^a   Walajtys Rode E ^b  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b RZESZOW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Alveolar macrophages; Anti TGF ; Arginase; Cyclosporin A; Manganese; Trichinella spiralis

Indexed keywords

ARGINASE; BCG VACCINE; CYCLOSPORIN A; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME RELEASE; GUINEA PIG; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRICHINELLA SPIRALIS; TRICHINOSIS;

ANIMALS; ANTIBODIES; ARGINASE; CELLS, CULTURED; CYCLOSPORINE; GUINEA PIGS; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MYCOBACTERIUM BOVIS; TRANSFORMING GROWTH FACTOR BETA; TRICHINELLA SPIRALIS; TRICHINOSIS;

ANIMALIA; CAVIA PORCELLUS; MYCOBACTERIUM BOVIS BCG; NEMATODA; SUS SCROFA; TRICHINELLA SPIRALIS;

EID: 4644370460     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9838.2004.00700.x     Document Type: Article

References (53)

1. O'Garra A & Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 1994; 6: 458-466.
2. Street NE & Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991; 5: 171-177.
3. Else KJ & Finkelman FD. Intestinal nematode parasites, cytokines and effector mechanisms. Int J Parasitol 1998; 28: 1145-1158.
4. Ishikawa N, Goyal PK, Mahida YR, Li KF & Wakelin D. Early cytokine responses during intestinal parasitic infections. Immunology 1998; 93: 257-263.
5. Mills CD, Kincaid K, Alt JM, Heilman MJ & Hill AM. M-1/M-2 macrophages and the Th1l/Th2 paradigm. J Immunol 2000; 164: 6166-6173.
6. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-212.
7. Hesse M, Modolell M, La Flamme AC, et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of 1-arginine metabolism. J Immunol 2001; 167: 6533-6544.
8. Wang CH & Bell RG. Trichinella spiralis: Vascular recirculation and organ retention of newborn larvae in rats. Exp Parasitol 1986; 62: 430-441.
9. Dzik JM, Gołos B, Jagielska E, Kapała A & Wałajtys-Rode E. Early response of guinea-pig lungs to Trichinella spiralis infection. Parasite Immunol 2002; 24: 369-379.
10. Coffman RL, Seymour BWP, Hudak S, Jackson J & Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989; 245: 308-310.
11. Zhang X & McMurray DN. Suppression of lymphoproliferation by alveolar macrophages in the guinea pig. Tubercle Lung Dis 1998; 79: 119-126.
12. Jesch NK, Dorger M, Enders G, et al. Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: an interspecies comparison. Environ Health Perspect 1997; 105 (Suppl. 5): 1297-1300.
13. 2 in murine bone-marrow-derived macrophages. Biochim Biophys Res Commun 1995; 206: 667-673.
14. Boutard V, Havouis R, Foucueray B, Philippe C, Moulinoux JP & Baud L. Transforming growth factor β stimulates arginase activity in macrophages. J Immunol 1995; 155: 2077-2084.
15. Wahl SM. Transforming growth factor beta (TGFβ) in inflammation: a cause and a cure. J Clin Immunol 1992; 12: 61-74.
16. Martinet Y, Menard O, Vaillant P, Vignaud JM & Martinet N. Cytokines in human lung fibrosis. Arch Toxicol Suppl 1996; 127: 18-39.
17. Prashar Y, Khanna P, Sehajpal P, Sharma VK & Suthanthiran M. Stimulation of transforming growth factor-beta 1 transcription by cyclosporine. FEBS Lett 1995; 358: 109-112.
18. Wolf G, Thaiss F & Stahl RA. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporine's antiproliferative effects. Transplantation 1995; 60: 237-241.
19. Dabrowska M, Zielinski Z, Wranicz M, Michalski R, Pawełczak K & Rode W. Trichinella spiralis thymidylate synthase: developmental pattern, isolation, molecular properties and inhibition by substrate and cofactor analogues. Biochem Biophys Res Commun 1996; 228: 440-445.
20. Lindor LJ, Wassom DL & Gleich GJ. Effects of trichinellosis on levels of eosinophils, eosinophil major basic protein, creatine kinase and basophils in the guinea pig. Parasite Immunol 1983; 5: 13-24.
21. Dzik JM, Zieliṅski Z, Gołos B, Jagielska E, Wranicz M & Wałajtys-Rode E. Effect of cyclosporin A on immunological response in lungs of guinea pigs infected with T. spiralis. Acta Biochim Polon 2002; 49: 233-247.
22. Coralizza IM, Campo ML, Soler G & Modolell M. Determination of arginase activity in macrophages: a micromethod. J Immunol Meth 1994; 174: 231-235.
23. Russell AS & Ruegg AT. Arginase production by peritoneal macrophages: a new assay. J Immunol Meth 1980; 32: 375-382.
24. Spector T. Refinement of the Coomassie Blue method of protein quantitation. Anal Biochem 1978; 86: 142-146.
25. Siegel S. Nonparametric Statistics for the Behavioral Sciences. Tokyo: McGraw-Hill Kogakusha; 1956.
26. Vodovotz Y. Control of nitric oxide production by transforming growth factor-β1: Mechanistic insight and potential relevance to human disease. Nitric Oxide 1997; 1: 3-17.
27. Saheki T, Sato Y, Takada S & Katsunuma T. Regulation of urea synthesis in rat liver. J Biochem 1979; 86: 745-750.
28. Bond JS, Failla ML & Unger DF. Elevated manganese concentration and arginase activity in livers of streptozotocin-induced diabetic rats. J Biol Chem 1983; 258: 8004-8009.
29. Reyero C & Dorner F. Purification of arginases from human-leukemic lymphocytes and granulocytes: study of their physicochemical and kinetic properties. Eur J Biochem 1975; 56: 137-147.
30. Kuhn NJ, Ward S, Piponski M & Young TW. Purification of human hepatic arginase and its manganese (II)-dependent and pH-dependent interconversion between active and inactive forms: a possible pH-sensing function of the enzyme on the ornithine cycle. Arch Biochem Biophys 1995; 320: 24-34.
31. Jenkinson CP, Grody WW & Cederbaum SD. Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 1996; 114B: 107-132.
32. Carraway MS, Piantadosi CA, Jenkinson CP & Huang YC. Differential expression of arginase and iNOS in the lung in sepsis. Exp Lung Res 1998; 24: 253-268.
33. Klasen S, Hammermann R, Fuhrmann M, et al. Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol 2001; 132: 1349-1357.
34. Currie GA. Activated macrophages kill tumour cells by releasing arginase. Nature 1978; 273: 758-759.
35. Murphy C & Newsholme P. Importance of glutamine metabolism in murine macrophages and human monocytes to 1-arginine biosynthesis and rates of nitrite or urea production. Clin Sci 1998; 95: 397-407.
36. Albina JE, Mills CD, Barbul A, et al. Arginine metabolism in wounds. Am J Physiol 1995; 254: E459-E467.
37. Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P & Kunkel SL. Role of monocyte chemoattractant protein-1 (Mcp-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol 1996; 15: 74602-74608.
38. Kawahara M, Nakasone T & Honda M. Dynamics of gamma interferon, interleukin-12 (IL-12), IL-10 and transforming growth factor beta mRNA expression in primary Mycobacterium bovis infection in guinea pigs measured by a real-time flurogenic reverse transcription-PCR assay. Infect Immun 2002; 70: 6614-6620.
39. Kim Y-M & Son KA. Nitric oxide production bioassay for interferon γ. J Immunol Meth 1996; 198: 203-209.
40. Hey C, Wessler I & Racké K. Nitric oxide synthase activity is inducible in the rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity. Naunyn-Schmideberg's Arch Pharmacol 1995; 351: 651-659.
41. Louis CA, Reichner JS, Henry WL Jr, et al. Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am J Physiol 1998; 274: R775-R782.
42. Iniesta V, Carlos Gomez-Nieto L, Molano I, et al. Arginase induction in macrophages, triggered by Th-2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol 2002; 24: 113-118.
43. Vincendeau P, Gobert AP, Daulouède S, Moynet D & Mossalayi MD. Arginases in parasitic diseases. Trends Parasitol 2003; 19: 9-12.
44. Stempin C, Giordanengo L, Gea S & Cerbán F. Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. J Leukoc Biol 2001; 72: 727-734.
45. 1 stimulates 1-arginine transport and metabolism in vascular smooth muscle cells. Circulation 2001; 103: 1121-1127.
46. Ulich TR, Yin S, Guo K, Yi ES, Remick D & Del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and Transforming growth factor beta inhibit acute inflammation. Am J Pathol 1991; 138: 1097-1101.
47. Spolarics Z & Bond JS. Comparison of biochemical properties of liver arginase from streptozotocin-induced diabetic and control mice. Arch Biochem Biophys 1989; 274: 426-433.
48. Frydas S, Karagouni E, Dotsika E, et al. Generation of TNF alpha, IFN gamma, IL-6, IL-4 and IL-10 in mouse serum from trichinellosis: effect of the anti-inflammatory compound 4-deoxypyridoxine (4-DPD). Immunol Lett 1996; 49: 179-184.
49. Johnson DW, Saunders HJ, Johnson FJ, Huq SO, Field MJ & Pollock CA. Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells roles of insulin-like growth factor I, transforming growth factor beta 1, and platelet-derived growth factor. J Pharmacol Exp Ther 1999; 289: 535-542.
50. Ghiggeri GM, Altieri P, Oleggini R, et al. Selective enhancement by Cyclosporin A of collagen expression by mesangial cells in culture. Eur J Pharmacol 1994; 270: 195-201.
51. Schincaglia GP, Forniti F, Cavallini R, Pira R, Calura G & del Senno L. Cyclosporin A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 1992; 21: 181-185.
52. Diez A, Fuentes J, Prada F, Campo L & Soler G. Immunological identity of the two different molecular mass constitutive subunits of liver arginase. Biol Chem Hoppe Seyler 1994; 375: 537-541.
53. Muijsers RB, ten Haken NH, Van Ark I, Folkerts G, Nijkamp FP & Postma DS. L-Arginine is not limiting factor for nitric oxide synthesis by human alveolar macrophage in vitro. Eur Respir J 2001; 186: 67-671.